| |
| |
|
| Insider
Information: |
Pacelli Steven Robert |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
142,975 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$14,819,527 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
142,975 |
|
|
| Total
Value |
$14,819,527 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 44.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
DexCom Inc |
DXCM |
EVP Managing Director ... |
2023-11-24 |
124,775 |
2008-11-19 |
0 |
Premium* |
|
|
Prosomnus, Inc. |
OSA |
|
2022-12-06 |
18,200 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DXCM |
DexCom Inc |
Managing Dir., Dexcom Ventures |
• – – |
2021-12-23 |
4 |
AS |
$573.91 |
$143,478 |
D/D |
(250) |
34,870 |
0 |
% |
|
| DXCM |
DexCom Inc |
Managing Dir., Dexcom Ventures |
• – – |
2021-10-22 |
4 |
AS |
$570.00 |
$142,500 |
D/D |
(250) |
40,829 |
0 |
% |
|
| DXCM |
DexCom Inc |
Managing Dir., Dexcom Ventures |
• – – |
2021-09-23 |
4 |
AS |
$569.63 |
$3,866,020 |
D/D |
(6,743) |
41,079 |
0 |
% |
|
| DXCM |
DexCom Inc |
Managing Dir., Dexcom Ventures |
• – – |
2021-09-09 |
4 |
S |
$541.36 |
$683,747 |
D/D |
(1,263) |
47,822 |
0 |
% |
|
| DXCM |
DexCom Inc |
Managing Dir., Dexcom Ventures |
• – – |
2021-08-23 |
4 |
AS |
$513.41 |
$556,678 |
D/D |
(1,078) |
49,085 |
0 |
% |
|
| DXCM |
DexCom Inc |
Managing Dir., Dexcom Ventures |
• – – |
2022-03-23 |
4 |
AS |
$459.98 |
$114,995 |
D/D |
(250) |
35,675 |
0 |
% |
|
| DXCM |
DexCom Inc |
Managing Dir., Dexcom Ventures |
• – – |
2021-07-23 |
4 |
AS |
$450.82 |
$487,897 |
D/D |
(1,079) |
50,163 |
0 |
% |
|
| DXCM |
DexCom Inc |
Managing Dir., Dexcom Ventures |
• – – |
2022-04-25 |
4 |
AS |
$439.94 |
$109,985 |
D/D |
(250) |
35,425 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2020-08-24 |
4 |
AS |
$427.24 |
$654,107 |
D/D |
(1,531) |
72,877 |
0 |
% |
|
| DXCM |
DexCom Inc |
Managing Dir., Dexcom Ventures |
• – – |
2021-06-23 |
4 |
AS |
$424.84 |
$460,651 |
D/D |
(1,079) |
51,242 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2020-07-23 |
4 |
AS |
$421.62 |
$654,213 |
D/D |
(1,531) |
74,408 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2021-02-19 |
4 |
AS |
$420.01 |
$756,025 |
D/D |
(1,800) |
56,902 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2020-10-01 |
4 |
AS |
$420.00 |
$84,000 |
D/D |
(200) |
63,018 |
0 |
% |
|
| DXCM |
DexCom Inc |
Managing Dir., Dexcom Ventures |
• – – |
2022-01-24 |
4 |
AS |
$416.77 |
$104,193 |
D/D |
(250) |
34,620 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2020-09-30 |
4 |
AS |
$410.28 |
$820,637 |
D/D |
(2,000) |
63,218 |
0 |
% |
|
| DXCM |
DexCom Inc |
Managing Dir., Dexcom Ventures |
• – – |
2021-04-23 |
4 |
AS |
$408.58 |
$442,727 |
D/D |
(1,079) |
53,400 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2020-06-23 |
4 |
AS |
$407.18 |
$626,750 |
D/D |
(1,531) |
75,939 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2021-02-23 |
4 |
AS |
$406.98 |
$439,131 |
D/D |
(1,079) |
55,823 |
0 |
% |
|
| DXCM |
DexCom Inc |
Managing Dir., Dexcom Ventures |
• – – |
2022-03-09 |
4 |
D |
$406.06 |
$1,392,368 |
D/D |
(3,429) |
35,925 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2020-09-25 |
4 |
AS |
$400.07 |
$800,137 |
D/D |
(2,000) |
65,218 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2020-09-09 |
4 |
S |
$398.30 |
$1,824,223 |
D/D |
(4,580) |
68,297 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2020-10-23 |
4 |
AS |
$397.49 |
$435,030 |
D/D |
(1,079) |
61,939 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2020-05-22 |
4 |
AS |
$396.74 |
$607,409 |
D/D |
(1,531) |
77,470 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2020-09-23 |
4 |
AS |
$395.11 |
$426,324 |
D/D |
(1,079) |
67,218 |
0 |
% |
|
| DXCM |
DexCom Inc |
Managing Dir., Dexcom Ventures |
• – – |
2022-02-23 |
4 |
AS |
$394.33 |
$98,583 |
D/D |
(250) |
34,370 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
